题目:Price Regulation and Product Offering in Healthcare


时间: 2024年4月11日(周四)14:30 – 15:30



Healthcare regulators possess the authority to set product prices, thereby influencing the strategic decision-making of service providers in terms of availability and quantity. The consequences of inadequate pricing can be substantial, leading to a reduced variety of products, a limited supply of treatments, and ultimately, restricted access to healthcare. This study examines the impact of Medicare payment policy on the product offerings of dialysis facilities, taking into account their capacity constraints, and assesses the subsequent effects on patient welfare. Our findings indicate that increasing payments for less expensive products leads to a rise in the total supply of treatments and a greater diversity of products, but this is only observed in facilities operating near their capacity limits. Additionally, these facilities are motivated to augment their capacity by opening new affiliated branches in nearby locations. Ultimately, our research shows that patients benefit from the increased availability of treatment options, with 16.5% of patients being able to retain employment post-initiation of dialysis without experiencing negative health consequences.



贾丹,北京师范大学湾区国际商学院助理教授,本科毕业于中国人民大学,获得法学学士学位。随后在香港大学获得经济学一等荣誉硕士学位(Distinction) 和经济学博士学位。主要研究方向是健康经济学和产业组织。